Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases

OBJECTIVE: Unlike several other national health agencies, French health authorities recommended that the newer direct oral anticoagulant (DOAC) agents only be prescribed as second choice for the treatment of newly diagnosed non-valvular atrial fibrillation (NVAF), with vitamin K antagonists (VKA) re...

Descripción completa

Detalles Bibliográficos
Autores principales: Huiart, Laetitia, Ferdynus, Cyril, Renoux, Christel, Beaugrand, Amélie, Lafarge, Sophie, Bruneau, Léa, Suissa, Samy, Maillard, Olivier, Ranouil, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884337/
https://www.ncbi.nlm.nih.gov/pubmed/29602837
http://dx.doi.org/10.1136/bmjopen-2017-018180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884337/
https://www.ncbi.nlm.nih.gov/pubmed/29602837
http://dx.doi.org/10.1136/bmjopen-2017-018180

Ejemplares similares